Author:
Lee Heesoon,Lee Chang-wook,Yang Sung-Il
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Drug Discovery,Molecular Medicine
Reference12 articles.
1. Atwell, G. J., Rewcastle, G. W. Baguley, B. C., Denny, W. A., Potential Antitumor Agents. 50. In vivo solid tumor activity of derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.J. Med. Chem., 30, 664–669 (1987).
2. Baguley, B. C., Zhuang, L., Marshall, E. M., Experimental solid tumor activity ofN-[2-(dimethylamino)ethyl]acridine-4-carboxamide.Cancer Chemother. Pharmacol., 36, 244–248 (1995).
3. Bonner, J. A., Kozelsky, T. F., The significance of the sequence of administration of topotecan and etoposide.Cancer Chemother. Pharmacol. 39, 109–12 (1996).
4. Cortes, F., Pinero, J., Synergistic effect of inhibitors of topoisomerase I and II on chromosome damage and cell killing in cultured Chinese hamster ovary cells.Cancer Chemother. Pharmacol., 34, 411–5 (1994).
5. Ishida, T., Nishio, K., Arioka, H., Kurokawa, H., Fukumoto, H., Fukuoka, K. Nomoto, T., Yokote, H., Saijo, N., TAS-103, a, novel dual inhibitor of DNA topoisomerase I and II.Proc. Am. Assoc. Cancer Res. 37, 428 (abstr. 2922) (1996)
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献